The Kentucky Neuroscience Institute integrates the expertise of UK's neurology and neurosurgery physicians and researchers.
KNI is a regional referral center dedicated to providing comprehensive care to our patients.
Stroke patients at the Kentucky Neuroscience Institute have access not only to the region's top doctors, but also to the most advanced medical technology. The stroke center at UK Chandler Hospital was the first in the region to be designated as a Primary Stroke Center.
The UK Neuro-Oncology Clinic offers an integrated, multispecialty program for diagnosis and treatment of patients with primary and secondary center nervous system tumors.
The clinic provides quick evaluation, treatment expertise and access to new therapies and clinical trials all under one roof. The multispecialty program allows patients to see a neurosurgeon, neuro-oncologist and radiation medicine experts in one visit, saving more time for patients and doctors. Learn more about the Neuro-Oncology Clinic.
UK is first in the U.S. to conduct trial of new Parkinson’s disease treatment
A clinical trial being conducted at UK is investigating a new treatment strategy for Parkinson’s disease that, if successful, could drastically change future treatment of the disease and possibly halt or reverse brain degeneration. UK is the first in the U.S. to conduct the clinical trial.
Craig van Horne, MD, associate professor of neurosurgery in the College of Medicine and principal investigator of the clinical trial, came to the Kentucky Neuroscience Institute only two years ago, but he is already making significant contributions to research and patient care related to Parkinson’s disease. If successful, this procedure could significantly change the treatment of Parkinson’s disease and could have an impact on other neurodegenerative disorders as well. Learn more.
LEXINGTON, Ky. (April 16, 2014) -- UK HealthCare's Kentucky Neuroscience Institute (KNI) has received the "Get With The Guidelines-Stroke Gold-Plus Quality Achievement Award" for maintaining specific quality measures outlined by the American Heart Association/American Stroke Association for the treatment of stroke patients.
KNI also received the association’s "Target: Stroke Honor Roll" for meeting stroke quality measures that reduce the time between hospital arrival and treatment with the clot-buster tPA, the only drug approved by the U.S. Food and Drug Administration to treat ischemic stroke. Stroke patients who receive the drug within three hours of the onset of symptoms may recover more quickly and are less likely to suffer severe disability.
This marks the fourth year that KNI has received this designation.
"This award provides patients with tangible evidence of KNI's commitment to the highest standard of stroke care," said Dr. Michael Dobbs, UK HealthCare's associate chief medical officer and chief of neurological services. "But patients aren't the only ones who benefit. By participating in the 'Get With The Guidelines-Stroke program,' we are able to share our expertise with other member hospitals around the country, including access to the most up-to-date research, clinical tools and resources, and patient education resources."
"What this means for Kentuckians is that the best possible stroke care is available right here in Lexington."
According to the American Heart Association/American Stroke Association, stroke is the number four cause of death and a leading cause of adult disability in the United States. In Kentucky, cardiovascular disease (which includes stroke) is the leading cause of death. On average, someone suffers a stroke every 40 seconds; someone dies of a stroke every four minutes; and 795,000 people suffer a new or recurrent stroke each year.
LEXINGTON, Ky. (April 10, 2014) -- The National Association of Epilepsy Centers (NAEC) has given Level 4 designation to the Comprehensive Epilepsy Center at the University of Kentucky's Kentucky Neuroscience Institute (KNI).
UK is the only Level 4 epilepsy center in the Bluegrass, and among 149 such centers in the United States. Level 4 of epilepsy care is the highest designation level offered by the NAEC.
"KNI has a commitment to providing the highest level and broadest range of treatment for its patients, and the NAEC Level 4 designation is yet another acknowledgement of our success in reaching that goal," said Dr. Michael R. Dobbs, interim chair of neurology and associate chief medical officer for UK HealthCare. "I'm delighted that the program has been recognized for its quality and range of care, and credit justly goes to the multidisciplinary team of physicians, nurses, rehabilitation specialists and staff that makes us worthy of this designation."
A Level 4 center provides the most complex forms of evaluation, including invasive brain monitoring and imaging and neuropsychological evaluation, and offers a broad range of medical and surgical treatment options.
"The epilepsy center has been providing the most comprehensive and specialized care to the people of Central and Eastern Kentucky for more than two decades," said Dr. Meriem Bensalem-Owen, director of KNI's Epilepsy Program. "Our epilepsy clinics, an active surgical program, and clinical trials offer a broad range of advanced forms of therapy for patients with difficult to control seizures. Those, in combination with our neuropsychological expertise and outreach efforts, make us the gold standard for epilepsy care in the bluegrass."
The NAEC is a non-profit group of more than 170 specialized epilepsy centers in the United States with the mission of setting a national agenda for quality epilepsy care.
Media Contact: Laura Dawahare, firstname.lastname@example.org
LEXINGTON, Ky. (April 3, 2014) -- Turning 21 is widely considered a milestone -- a time when life's possibilities appear unlimited. At first, this was not so for Marietta Barton-Baxter. She was diagnosed with multiple sclerosis (MS) at 21. "When I first heard that I had MS, I was scared and angry," Barton-Baxter says. "I felt as if I had been robbed of all my dreams and my future."
But once she adjusted to her new situation, she began to make the proverbial lemonade out of lemons. She has worked at the University of Kentucky for 26 years, and is currently an administrative director for the Regulatory and Clinical Services Cores at the Center for Clinical and Translational Science (CCTS). She and her husband have travelled around the country doing motivational talks for MS patients and their care partners, and she continues to be an MS patient advocate, assisting newly diagnosed MS patients and their families. "It feels good to help patients and their families through the emotional times that come post-diagnosis," she says.
And now, the people at UK who have found her story inspiring have the opportunity to acknowledge her efforts. On May 31, 2014, staff from the UK Kentucky Neuroscience Institute (KNI) and CCTS will join Barton-Baxter at Walk MS Lexington.
"Marietta amazes us with her commitment to helping others at a time when it would be easy to focus on her own health," says Amber Mccormick, the Multiple Sclerosis Coordinator at KNI. "It seems fitting that we honor her efforts this way."
Multiple sclerosis (MS) is an inflammatory disease that damages the insulating covers of nerves in the brain and spinal cord, resulting in physical, mental, and sometimes psychiatric problems. Between 2 and 2.5 million people around the world have been diagnosed with MS, which is twice as common in women as in men. There is no known cure for multiple sclerosis, but there are several medications that can be used to manage symptoms. Barton-Baxter has been taking injections every other day for more than 20 years with tremendous success.
But, Barton-Baxter says, her hope for herself and for others is a cure. Proceeds from Walk MS helps to fund multiple sclerosis research efforts. "I don't want to see anyone else suffer from this debilitating disease," she says.
The Walk MS event will take place on Saturday, May 31 at the RJ Corman Railroad property; 101 RJ Corman Drive in Nicholasville. There are one and three mile course options. Walk registration will begin at 9 a.m.; walk begins at 10 a.m. For more information, contact Amber Mccormick at 859-323-5661 or email@example.com.
LEXINGTON, Ky. (Feb. 24, 2014) -- Leadership from the UK HealthCare's stroke team has been invited to assist The American Heart Association/American Stroke Association in a "prep visit" to the Cleveland Clinic as their stroke center applies for Comprehensive Stroke Center (CSC) designation from The Joint Commission.
Kelley Elkins, UK HealthCare Stroke program coordinator, and Lisa Bellamy, director of education and quality for the UK HealthCare/Norton Healthcare-Stroke Care Network, will travel to Cleveland to share their experience with the CSC application process, which UK HealthCare completed late last year.
The prep visit is funded by the American Heart Association/American Stroke Association and is designed to help institutions applying for CSC designation understand TJC's expectations for accreditation.
"When we were working towards our CSC designation, we received the same type of support from AHA/ASA and from Riverside Methodist Hospital in Columbus, Ohio, which helped us considerably as we prepared for our site visit from TJC," said Elkins. " Interpreting the CSC standards can be challenging, and we hope our experiences can help The Cleveland Clinic achieve their goal of CSC designation."
The invitation comes just two months after UK HeathCare earned its own CSC designation, which is the highest honor TJC awards to stroke centers. UK HealthCare is one of only 63 U.S. institutions with CSC designation.
"It's quite a compliment that we've been asked to do this so soon after our own designation was announced," says Bellamy. "This type of sharing process prevents each institution from having to recreate the wheel, which is also what the Stroke Care Network is about."
The UK HealthCare/Norton HealthCare Stroke Care Network is a unique program dedicated to community education and standards-sharing with affiliate hospitals in Kentucky and West Virginia.
The Joint Commission is the nation's oldest and largest standards-setting and evaluation body in health care. An independent, not-for-profit organization, The Joint Commission evaluates and accredits more than 20,000 healthcare organizations and programs in the US.
LEXINGTON, Ky. (Feb. 20, 2014) -- Dr. Meriem Bensalem-Owen, associate professor of neurology, anatomy and neurobiology and director of UK HealthCare's Epilepsy Program, has been named a fellow of the American Clinical Neurophysiology Society (ACNS), a professional association dedicated to fostering excellence in clinical neurophysiology.
In addition to serving on the society's program committee, the Committee for Continuing Medical Education, and the Website/Social Media Committee, Dr. Bensalem-Owen will co-chair the Mentoring Program of the ACNS.
"This is a great honor for Dr. Bensalem- Owen as she is the first UK faculty member to be named a fellow of this prestigious society," said Dr. Michael Dobbs, associate chief medical officer for UK HealthCare and interim chair for the Department of Neurology. "She has represented herself, the University of Kentucky, and The Kentucky Neuroscience Institute well."
The UK Brain and Body Radiosurgery Program offers the most advanced radiosurgery options available, and our recent upgrade to the Gamma Knife ® Perfexion ™ allows us to offer the most innovative treatment available.
Spine Care Outreach ClinicSt. Claire Regional Outpatient Center1028 E. Main St.Morehead KY 40351859-323-5928
Brain Injury Association of Americawww.biausa.org
Trigeminal Neuralgia Associationwww.tna-support.org
American Academy of Neurologywww.aan.com
American Association of Neurological Surgeonswww.neurosurgery.org
National Institute of Neurological Disorders and Strokewww.ninds.nih.gov/disorders/stroke/knowstroke.htm
National Brain Tumor Foundationwww.braintumor.org
American Brain Tumor Associationwww.abta.org
Advances & InsightsThis publication provides up-to-the-minute medical news along with commentary from a UK HealthCare expert.
Read online | Subscribe free | Neurosciences topics
This is a clinic of the University of Kentucky Hospital, also known as UK Albert B. Chandler Hospital. Read more »
Kentucky Neuroscience Institute ClinicKentucky Clinic First floor, Wing C (across from Starbucks) 740 South Limestone Lexington, KY 40536-0284
Directions | Parking
Patients seeking appointments with our specialists are generally referred to Kentucky Neuroscience Institute by their physicians. Call 859-257-1000 or toll free 1-800-333-8874 to make an appointment with a general physician.
As a leader in stroke diagnosis and evidence-based treatment, UK has joined with Norton Healthcare to help community hospitals throughout the state provide timely, accurate diagnosis and treatment for those suffering strokes. Understanding “time lost is brain lost,” we are training, guiding and advising emergency care providers in participating community hospitals so that patients can receive these time-sensitive treatments closer to home and in time to make a real difference. Find out more about the network and see which hospitals participate.
connected with UK HealthCare and Kentucky Neuroscience Institute. Become a fan
of KNI's Facebook to stay up-to-date on community events, programs,
treatments, research, new physicians and more.
© University of Kentucky, Lexington, Kentucky, USA | An Equal Opportunity University